T-Cell DPP4 Expression Is Related With Metabolic Control and Serum Interleukin-2 Level in Patients With Type 2 Diabetes Mellitus

被引：0
|
作者：
Jo, Jaemin
Kim, Young Ree
Lee, Sang Ah
Koh, Gwanpyo
Lee, Dae Ho
机构：
来源：
DIABETES | 2013年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1681-P
引用
收藏
页码：A439 / A439
页数：1
相关论文
共 50 条
  • [1] DPP4 Expression in Peripheral Blood T Cells Is Related with Glucose Control in Patients with Type 2 Diabetes Mellitus
    Yu, Jung-Re
    Kim, Youngree
    Koh, Gwanpyo
    Lee, Dae Ho
    DIABETES, 2011, 60 : A402 - A402
  • [2] Impact of DPP4 Inhibition on Survival in Patients With Metastatic Renal Cell Carcinoma and Type 2 Diabetes Mellitus
    Ali, Soham
    Fortune, Kathryn
    Masur, Jack
    Viscuse, Paul Vincent
    Devitt, Michael Edward
    Dreicer, Robert
    Skelton IV, William Paul
    CLINICAL GENITOURINARY CANCER, 2024, 22 (05)
  • [3] Pioglitazone Increases Serum DPP-4 Level in Type 2 Diabetes Mellitus
    Kanazawa, Ippei
    Tanaka, Sayuri
    Notsu, Masakazu
    Sugimoto, Toshitsugu
    JOURNAL OF DIABETES & METABOLISM, 2014, 5 (08)
  • [4] CD26/DPP4 Levels in Peripheral Blood and T Cells in Patients With Type 2 Diabetes Mellitus
    Lee, Sang Ah
    Kim, Young Ree
    Yang, Eun Jin
    Kwon, Eun-Jeong
    Kim, Sun Hyung
    Kang, Sung Ha
    Park, Doek Bae
    Oh, Byung-Chul
    Kim, Jinseok
    Heo, Sang Taek
    Koh, Gwanpyo
    Lee, Dae Ho
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (06): : 2553 - 2561
  • [5] Polyarthropathy in type 2 diabetes patients treated with DPP4 inhibitors
    Saito, Tatsuhiko
    Ohnuma, Kei
    Suzuki, Hiroshi
    Dang, Nam H.
    Hatano, Ryou
    Ninomiya, Hiroki
    Morimoto, Chikao
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2013, 102 (01) : E8 - E12
  • [6] Association of DPP4 Gene Polymorphisms with Type 2 Diabetes Mellitus in Malaysian Subjects
    Ahmed, Radwan H.
    Huri, Hasniza Zaman
    Al-Hamodi, Zaid
    Salem, Sameer D.
    Al-absi, Boshra
    Muniandy, Sekaran
    PLOS ONE, 2016, 11 (04):
  • [7] Level of metabolic control among patients with diabetes mellitus type 2
    Pejic, D.
    Tomic, A.
    Cvijanovic-Benke, S.
    Nikolic, R.
    SWISS MEDICAL WEEKLY, 2009, 139 (33-34) : 156S - 157S
  • [8] Reduction of serum FABP4 level by sitagliptin, a DPP-4 inhibitor, in patients with type 2 diabetes mellitus
    Furuhashi, Masato
    Hiramitsu, Shinya
    Mita, Tomohiro
    Fuseya, Takahiro
    Ishimura, Shutaro
    Omori, Akina
    Matsumoto, Megumi
    Watanabe, Yuki
    Hoshina, Kyoko
    Tanaka, Marenao
    Moniwa, Norihito
    Yoshida, Hideaki
    Ishii, Junnichi
    Miura, Tetsuji
    JOURNAL OF LIPID RESEARCH, 2015, 56 (12) : 2372 - 2380
  • [9] COST-UTILITY OF DAPAGLIFLOZIN VERSUS DPP4 INHIBITORS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN COLOMBIA
    Ordonez, J. E.
    VALUE IN HEALTH, 2017, 20 (05) : A172 - A172
  • [10] Influencing factors of metabolic control level in patients with diabetes mellitus type 2
    Reviriego, J.
    Diago, J.
    Polavieja, P.
    Chacon, F.
    DIABETOLOGIA, 2008, 51 : S413 - S413
12345